CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice
Pancreatic cancer is known for its tumor microenvironment (TME), which is rich in stromal and immune cells supporting cancer growth and therapy resistance. In particular, tumor-associated macrophages (TAMs) are known for their angiogenesis- and metastasis-promoting properties, which lead to the fail...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/11/6/1517 |
| _version_ | 1827738488863195136 |
|---|---|
| author | Aydar Khabipov Dung Nguyen Trung Julia van der Linde Lea Miebach Maik Lenz Felix Erne Wolfram von Bernstorff Tobias Schulze Stephan Kersting Sander Bekeschus Lars Ivo Partecke |
| author_facet | Aydar Khabipov Dung Nguyen Trung Julia van der Linde Lea Miebach Maik Lenz Felix Erne Wolfram von Bernstorff Tobias Schulze Stephan Kersting Sander Bekeschus Lars Ivo Partecke |
| author_sort | Aydar Khabipov |
| collection | DOAJ |
| description | Pancreatic cancer is known for its tumor microenvironment (TME), which is rich in stromal and immune cells supporting cancer growth and therapy resistance. In particular, tumor-associated macrophages (TAMs) are known for their angiogenesis- and metastasis-promoting properties, which lead to the failure of conventional therapies for pancreatic cancer. Hence, treatment options targeting TAMs are needed. The C-C chemokine receptor type 4 (CCR4) is critical for immune cell recruitment into the TME, and in this paper we explore the effects of its genetic or immunotherapeutic blockade in pancreatic-cancer-bearing mice. Murine PDA6606 pancreatic cancer cells and murine peritoneal macrophages were used for in vitro migration assays. In vivo, a syngeneic, orthotropic pancreatic cancer model was established. Tumor growth and survival were monitored under prophylactic and therapeutic application of a CCR4 antagonist (AF-399/420/18025) in wildtype (CCR4<sup>wt</sup>) and CCR4-knockout (CCR4<sup>−/−</sup>) mice. Immune infiltration was monitored in tumor tissue sections and via flow cytometry of lysed tumors. PDA6606 cells induced less migration in CCR4<sup>−/−</sup> than in CCR4<sup>wt</sup> macrophages in vitro. Pancreatic TAM infiltration was higher, and survival was reduced in CCR4<sup>wt</sup> mice compared to CCR4<sup>−/−</sup> mice. Antagonizing CCR4 in wildtype mice revealed similar results as in CCR4<sup>−/−</sup> mice without antagonization. Prophylactic CCR4 antagonist application in wildtype mice was more efficient than therapeutic antagonization. CCR4 seems to be critically involved in TAM generation and tumor progression in pancreatic cancer. CCR4 blockade may help prolong the relapse-free period after curative surgery in pancreatic cancer and improve prognosis. |
| first_indexed | 2024-03-11T02:45:04Z |
| format | Article |
| id | doaj.art-bec27ca07afa4204aedbb7fa7392ad1e |
| institution | Directory Open Access Journal |
| issn | 2227-9059 |
| language | English |
| last_indexed | 2024-03-11T02:45:04Z |
| publishDate | 2023-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj.art-bec27ca07afa4204aedbb7fa7392ad1e2023-11-18T09:24:28ZengMDPI AGBiomedicines2227-90592023-05-01116151710.3390/biomedicines11061517CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing MiceAydar Khabipov0Dung Nguyen Trung1Julia van der Linde2Lea Miebach3Maik Lenz4Felix Erne5Wolfram von Bernstorff6Tobias Schulze7Stephan Kersting8Sander Bekeschus9Lars Ivo Partecke10Department of General, Thoracic, Visceral, and Vascular Surgery, Greifswald University Medical Center, Ferdinand-Sauerbruch-Str., 17475 Greifswald, GermanyDepartment of General, Thoracic, Visceral, and Vascular Surgery, Greifswald University Medical Center, Ferdinand-Sauerbruch-Str., 17475 Greifswald, GermanyDepartment of General, Thoracic, Visceral, and Vascular Surgery, Greifswald University Medical Center, Ferdinand-Sauerbruch-Str., 17475 Greifswald, GermanyDepartment of General, Thoracic, Visceral, and Vascular Surgery, Greifswald University Medical Center, Ferdinand-Sauerbruch-Str., 17475 Greifswald, GermanyDepartment of General, Thoracic, Visceral, and Vascular Surgery, Greifswald University Medical Center, Ferdinand-Sauerbruch-Str., 17475 Greifswald, GermanyDepartment of General, Thoracic, Visceral, and Vascular Surgery, Greifswald University Medical Center, Ferdinand-Sauerbruch-Str., 17475 Greifswald, GermanyDepartment of General, Thoracic, Visceral, and Vascular Surgery, Greifswald University Medical Center, Ferdinand-Sauerbruch-Str., 17475 Greifswald, GermanyDepartment of General, Thoracic, Visceral, and Vascular Surgery, Greifswald University Medical Center, Ferdinand-Sauerbruch-Str., 17475 Greifswald, GermanyDepartment of General, Thoracic, Visceral, and Vascular Surgery, Greifswald University Medical Center, Ferdinand-Sauerbruch-Str., 17475 Greifswald, GermanyZIK <i>plasmatis</i>, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, GermanyDepartment of General, Thoracic, Visceral, and Vascular Surgery, Greifswald University Medical Center, Ferdinand-Sauerbruch-Str., 17475 Greifswald, GermanyPancreatic cancer is known for its tumor microenvironment (TME), which is rich in stromal and immune cells supporting cancer growth and therapy resistance. In particular, tumor-associated macrophages (TAMs) are known for their angiogenesis- and metastasis-promoting properties, which lead to the failure of conventional therapies for pancreatic cancer. Hence, treatment options targeting TAMs are needed. The C-C chemokine receptor type 4 (CCR4) is critical for immune cell recruitment into the TME, and in this paper we explore the effects of its genetic or immunotherapeutic blockade in pancreatic-cancer-bearing mice. Murine PDA6606 pancreatic cancer cells and murine peritoneal macrophages were used for in vitro migration assays. In vivo, a syngeneic, orthotropic pancreatic cancer model was established. Tumor growth and survival were monitored under prophylactic and therapeutic application of a CCR4 antagonist (AF-399/420/18025) in wildtype (CCR4<sup>wt</sup>) and CCR4-knockout (CCR4<sup>−/−</sup>) mice. Immune infiltration was monitored in tumor tissue sections and via flow cytometry of lysed tumors. PDA6606 cells induced less migration in CCR4<sup>−/−</sup> than in CCR4<sup>wt</sup> macrophages in vitro. Pancreatic TAM infiltration was higher, and survival was reduced in CCR4<sup>wt</sup> mice compared to CCR4<sup>−/−</sup> mice. Antagonizing CCR4 in wildtype mice revealed similar results as in CCR4<sup>−/−</sup> mice without antagonization. Prophylactic CCR4 antagonist application in wildtype mice was more efficient than therapeutic antagonization. CCR4 seems to be critically involved in TAM generation and tumor progression in pancreatic cancer. CCR4 blockade may help prolong the relapse-free period after curative surgery in pancreatic cancer and improve prognosis.https://www.mdpi.com/2227-9059/11/6/1517CCL17CCL22M2 macrophagesmigrationTAMstumor-associated macrophages |
| spellingShingle | Aydar Khabipov Dung Nguyen Trung Julia van der Linde Lea Miebach Maik Lenz Felix Erne Wolfram von Bernstorff Tobias Schulze Stephan Kersting Sander Bekeschus Lars Ivo Partecke CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice Biomedicines CCL17 CCL22 M2 macrophages migration TAMs tumor-associated macrophages |
| title | CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice |
| title_full | CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice |
| title_fullStr | CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice |
| title_full_unstemmed | CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice |
| title_short | CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice |
| title_sort | ccr4 blockade diminishes intratumoral macrophage recruitment and augments survival of syngeneic pancreatic cancer bearing mice |
| topic | CCL17 CCL22 M2 macrophages migration TAMs tumor-associated macrophages |
| url | https://www.mdpi.com/2227-9059/11/6/1517 |
| work_keys_str_mv | AT aydarkhabipov ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice AT dungnguyentrung ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice AT juliavanderlinde ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice AT leamiebach ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice AT maiklenz ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice AT felixerne ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice AT wolframvonbernstorff ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice AT tobiasschulze ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice AT stephankersting ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice AT sanderbekeschus ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice AT larsivopartecke ccr4blockadediminishesintratumoralmacrophagerecruitmentandaugmentssurvivalofsyngeneicpancreaticcancerbearingmice |